Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 30, 2019 | PathogenDx raises $7.5m Series B for cannabis pathogen testing, eyes food | Most people know that certain food items like leafy greens and meat can contain dangerous pathogens like e. Coli, but the nasty bug is also a problem for the burgeoning cannabis industry. “Anything grow can grow e. Coli on it if it’s in a h... |
| Jun 6, 2019 | Cresco Capital Partners Raises $60M | Cresco Capital Partners, a private equity investment firm focused solely on making strategic investments in the legal cannabis market, announced today the closing of an oversubscribed $60 million fund (CCP Fund II). Since inception in 2014,... |
| Jun 6, 2019 | Cresco Capital Partners Closes Second Cannabis Fund, at $60M | Cresco Capital Partners, a NYC-based private equity firm focused on the legal cannabis industry, closed $60m for its second fund. CCP Fund II has already deployed approximately $22m to date from Fund II in 15 companies that operate across t... |
Reviews 0
FAQ about Cresco Capital Partners
When was Cresco Capital Partners founded?
Cresco Capital Partners was founded in 2014.
How much funding has Cresco Capital Partners raised?
Cresco Capital Partners has raised $60M in total across 1 funding round.
What has the press written about Cresco Capital Partners?
Parsers VC has collected 4 articles mentioning Cresco Capital Partners, among them “PathogenDx raises $7.5m Series B for cannabis pathogen testing, eyes food” (Sep 30, 2019) and “Cresco Capital Partners Raises $60M” (Jun 6, 2019).
Is Cresco Capital Partners still active?
Yes, Cresco Capital Partners is active; its latest activity on Parsers VC dates from Apr 15, 2020.